OH2 Oncolytic Viral Therapy in Central Nervous System Tumors

NCT05235074 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Tumors

Interventions

BIOLOGICAL: OH2 injection

Sponsor

Binhui Biopharmaceutical Co., Ltd.